SurvivorNet on MSN
'Practice-changing': FDA approves Ibrance combination as new maintenance option for HR+/HER2+ metastatic breast cancer
The FDA has approved palbociclib (Ibrance) in combination with trastuzumab (Herceptin), endocrine therapy, and optionally ...
Engineers have developed a new way to monitor how tiny lab-grown human heart tissues beat—by effectively "listening" to the ...
Researchers at Hospital for Special Surgery (HSS) have uncovered a critical link between the immune system in early life and ...
Nano-sized outer membrane vesicles (OMVs) are lipid-bilayered structures that primarily encapsulate periplasmic components, with minor inclusion of cytoplasmic materials. Rather than passive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results